Drug Shortage Report for TEVA-SOLIFENACIN
Report ID | 152417 |
Drug Identification Number | 02397919 |
Brand name | TEVA-SOLIFENACIN |
Common or Proper name | SOLIFENACIN 10MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SOLIFENACIN SUCCINATE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-05 |
Estimated end date | 2022-08-30 |
Actual end date | 2022-08-18 |
Shortage status | Resolved |
Updated date | 2022-08-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.